Predictive Value of PS Application in Premature Infants With RDS

Predictive Value of PS Application in Premature Infants With RDS by Different Pulmonary Ultrasound Scores: a Prospective Multicenter Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05772247

Enrollment

1392

Registered

2023-03-16

Start date

2023-04-01

Completion date

2023-12-31

Last updated

2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome

Brief summary

A multicenter prospective study was conducted to compare the predictive value of 6-zone, 10-zone, and 12-zone LUS scores for PS application in early and late preterm infants.

Interventions

DIAGNOSTIC_TESTLung ultrasound

Lung ultrasound score was calculated by the results of lung ultrasound examination

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 1 Months

Healthy volunteers

Inclusion criteria

1. Hospital admission within 2 hours after birth; 2. The diagnosis was RDS; 3. Parents agree to attend

Exclusion criteria

1. chromosomal abnormalities or complex congenital malformations; 2. congenital pulmonary disease; 3. severe sepsis, disseminated intravascular coagulation, septic shock and other critical conditions; 4. LUS and blood gas analysis have been examined before the application of alveolar surfactant.

Design outcomes

Primary

Measure	Time frame	Description
Whether the patient uses ps (pulmonary surfactant)	2023.2-2023.12	The standards used by PS are based on the European consensus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026